Rituximab plus chlorambucil extend event-free survival in MALT lymphoma – The Oncology Report
Rituximab plus chlorambucil extend event-free survival in MALT lymphomaThe Oncology ReportPatients who have mucosa-associated lymphoid tissue lymphoma and are treated with chlorambucil plus rituximab have better event-free survival and progression-free…
